KR890014110A - 의약제 - Google Patents

의약제 Download PDF

Info

Publication number
KR890014110A
KR890014110A KR1019890002612A KR890002612A KR890014110A KR 890014110 A KR890014110 A KR 890014110A KR 1019890002612 A KR1019890002612 A KR 1019890002612A KR 890002612 A KR890002612 A KR 890002612A KR 890014110 A KR890014110 A KR 890014110A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
therapeutic agent
inflammatory agent
supotidine
free base
Prior art date
Application number
KR1019890002612A
Other languages
English (en)
Korean (ko)
Inventor
스테이블스 로저
토마스 번스 케이쓰
Original Assignee
원본 미기재
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본 미기재, 글락소 그룹 리미티드 filed Critical 원본 미기재
Publication of KR890014110A publication Critical patent/KR890014110A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
KR1019890002612A 1988-03-04 1989-03-03 의약제 KR890014110A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments
GB8805268 1988-03-04

Publications (1)

Publication Number Publication Date
KR890014110A true KR890014110A (ko) 1989-10-21

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890002612A KR890014110A (ko) 1988-03-04 1989-03-03 의약제

Country Status (12)

Country Link
JP (1) JP2834175B2 (da)
KR (1) KR890014110A (da)
AU (1) AU3098489A (da)
BE (1) BE1002256A3 (da)
DE (1) DE3906884A1 (da)
DK (1) DK104489A (da)
FR (1) FR2627985A1 (da)
GB (2) GB8805268D0 (da)
IT (1) IT8947714A0 (da)
NL (1) NL8900525A (da)
SE (1) SE8900752L (da)
ZA (1) ZA891640B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
CN1158994C (zh) * 1999-09-24 2004-07-28 爱尔康公司 含环丙沙星和地塞米松的局部悬浮制剂
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477150A1 (fr) * 1980-02-28 1981-09-04 Glaxo Group Ltd Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
FR2627985A1 (fr) 1989-09-08
AU3098489A (en) 1989-09-07
GB8805268D0 (en) 1988-04-07
GB2216413A (en) 1989-10-11
GB8904879D0 (en) 1989-04-12
IT8947714A0 (it) 1989-03-03
SE8900752L (sv) 1989-09-05
DE3906884A1 (de) 1989-09-14
DK104489D0 (da) 1989-03-03
NL8900525A (nl) 1989-10-02
JP2834175B2 (ja) 1998-12-09
BE1002256A3 (fr) 1990-11-06
DK104489A (da) 1989-09-05
SE8900752D0 (sv) 1989-03-03
JPH01316319A (ja) 1989-12-21
ZA891640B (en) 1990-03-28

Similar Documents

Publication Publication Date Title
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
RU2000123567A (ru) Фармацевтическая композиция, содержащая в комбинации метформин и фибрат, и ее применение при приготовлении лекарственных средств, предназначенных для снижения гипергликемии
PT100635A (pt) Forma de dosagem farmaceutica para a administracao retardada de um farmaco
KR930009605A (ko) 소염 또는 진통제
KR930007441A (ko) 의약품
PT866713E (pt) Meios de administração para fármacos analgésicos, anti-inflamatórios e antipiréticos contendo óxido de azoto e composições farmacêuticas contendo esses meios e fármacos
BR122012014331A8 (pt) Formulações farmacêuticas
KR910009254A (ko) 과식 및/또는 과음후 증상을 치료하기 위한 약제학적 조성물 및 방법
Pfaffenrath et al. Analgesics and NSAIDs in the treatment of the acute migraine attack
KR920700630A (ko) 발현-촉진/증강된 해열성반응
Catapano The analgesic efficacy of ketorolac for acute pain
KR890014110A (ko) 의약제
KR970705390A (ko) 비마약성 진통제(non-narcotic analgesic) 및 진통효과 향상제(analgesia enhancer)를 포함하는 통증 완화 조성물(COMPOSITION ALLEVIATING PAIN, CONTAINING A NON-NARCOTIC ANALGESIC AND AN ANALGESIA ENHANCER)
Lynch et al. Etodolac: a preliminary review of its pharmacodynamic activity and therapeutic use
JPH0314812B2 (da)
JP2016014064A (ja) 医薬組成物
JP2015164945A (ja) ロキソプロフェンを含む医薬組成物
KR890014109A (ko) 의약제
WO2004093864A1 (en) Non-steroidal anti-inflammatory drug dosing regimen
KR890007728A (ko) 진통제 제조방법
JP2000500159A (ja) メラトニンと組み合わせた鎮痛剤
JP2011225508A (ja) ロキソプロフェン含有医薬製剤
CA1141664A (en) Analgesic composition
RU2002129356A (ru) Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство
JP5798734B2 (ja) ロキソプロフェン含有医薬の組成物

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid